Dicot
Phase 2Dicot Pharma is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.
Founded
2017
Focus
Small Molecules
About
Dicot Pharma is developing a modern potency drug that will treat erectile dysfunction and premature ejaculation better than existing drugs.
Funding History
2Total raised: $6.2M
Series A$5MFlerie InvestJun 15, 2022
Seed$1.2MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2017
LocationUppsala, Sweden
StagePhase 2
Contact
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile